Amgen Inc. buy Royal Bank of Canada
Start price
03.05.24
/
50%
€290.40
Target price
03.05.25
€304.65
Performance (%)
-15.00%
End price
04.05.25
€246.85
Summary
This prediction ended on 04.05.25 with a price of €246.85. The prediction for Amgen Inc. disappointed with a performance of -15.00%. Royal_Bank_of_Canada has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. Dividends of €8.50 are taken into consideration when calculating the performance. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | 3.148% | 3.148% | 27.722% |
| iShares Core DAX® | 4,57 % | 4,14 % | 7,35 % |
| iShares Nasdaq 100 | 1,83 % | -1,64 % | 33,64 % |
| iShares Nikkei 225® | -0,29 % | 2,47 % | 60,45 % |
| iShares S&P 500 | 2,23 % | 0,71 % | 24,13 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at Royal Bank of Canada from $332.00 to $328.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten